The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomas

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1259-1263

  Tan, Puay ^a   Cady, Blake ^a   Wanner, Molly ^a   Worland, Peter ^b   Cukor, Barry ^a   Magi Galluzzi, Cristina ^a   Lavin, Philip ^c   Draetta, Giulio ^d   Pagano, Michele ^e   Loda, Massimo ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GPC Biotech Inc   (United States)

^c Boston Biostatistics Research Foundation   (United States)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INVASION; CELL CYCLE; DEPHOSPHORYLATION; FEMALE; GENE DELETION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; BREAST NEOPLASMS; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PHOSPHOPROTEIN PHOSPHATASE; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0030894787     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cady, B., Stone, M., Schuler, J., Thakur, R., Wanner, M., and Lavin, P. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg., 131: 301-30, 1996.
2. Thor, A. D., Moore, D. H. II, Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L. C., Mayall, B. H., and Smith, H. S. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. Natl. Cancer, Inst., 84: 845-855, 1992.
3. Esteban, J. M., Ahn, C., Battifora, H., and Felder, B. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer. Am. J. Clin. Pathol., 102(Suppl. 1): S9-S12, 1994.
4. Slamon, D., Clark, G., Wong, S., Levin, W., Ullrich, A., and McGuire, W. Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
5. Finder, S. E., Wencyk, P., Sibbering, D. M., Bell, J. A., Elston, C. W., Nicholson, R., Robertson, J. F., Blarney, R. W., and Ellis, I. O. Assessment of new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br. J. Cancer, 71: 146-149, 1995.
6. Bosari, S., Lee, A., DeLellis, R., Wiley, B., Heatley, G., and Silverman, M. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23: 755-761, 1992.
7. Jacquemier, J., Kurtz, J. M., and Amalric, R. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br. J. Cancer, 61: 873-876, 1990.
8. Lees, E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol., 773-780, 1995.
9. Coleman, T., and Dunphy, W. cdc2 regulatory factors. Curr. Opin. Cell Biol., 6: 877-882, 1994.
10. Sherr, C., and Roberts, J. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
11. Kip1 display increased body size, multiple organ hyperplasia, retina dysplasia, and pituitary tumors. Cell, 85: 707-721, 1996.
12. Kip1. Cell, 85: 721-732, 1996.
13. Kip1-deficient mice. Cell, 85: 733-744, 1996.
14. Mal, A., Poon, R., Howe, P., Toyoshima, H., Hunter, T., and Harter, M. Inactivation of p27kip1 by the viral E1 A oncoprotein in TGFβ-treated cells. Nature (Lond.), 380: 262-265, 1996.
15. Kawamata, N., Morosetti, R., Miller, C., Park, D., Spirin, K., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y., Bartram, C., and Koeffler, H. Molecular analysis of the cyclin-dependem kinase inhibitor gene p27/ kip1 in human malignancies. Cancer Res., 55: 2266-2269, 1995.
16. Spirin, K. S., Simpson, J. F., Takeuchi, S., Kawamata, N., Miller, C. W., and Koeffler, H. P. p27/Kip1 mutation found in breast cancer. Cancer Res., 56: 2400-2404, 1996.
17. Pagano, M., Tam, S. W., Theodoras, A. M., Romero-Beer, P., Del Sal, G., Chau, V., Yew, R., Draetta, G., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
18. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G., Jessup, J., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231-234, 1997.
19. Galaktionov, K., Lee, A., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. CDC25 phosphatases as potential human oncogenes. Science (Washington DC), 269: 1575-1577, 1995.
20. Allred, D. C., Bustamante, M. A., Daniel, C. O., Gaskill, H. V., and Cruz, A. B. J. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Arch. Surg., 125: 107-113, 1990.